R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies.
- DOI
- 10.1038/sj.bjc.6604025
- Published
- 2007 Nov 19
- Container
- British journal of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/sj.bjc.6604025,
title = {R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies.},
author = {Arts J and Angibaud P and Mariën A and Floren W and Janssens B and King P and van Dun J and Janssen L and Geerts T and Tuman RW and Johnson DL and Andries L and Jung M and Janicot M and van Emelen K},
year = {2007},
journal = {British journal of cancer},
doi = {10.1038/sj.bjc.6604025},
url = {https://doi.org/10.1038/sj.bjc.6604025}
}RIS
TY - JOUR TI - R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies. AU - Arts J AU - Angibaud P AU - Mariën A AU - Floren W AU - Janssens B AU - King P AU - van Dun J AU - Janssen L AU - Geerts T AU - Tuman RW AU - Johnson DL AU - Andries L AU - Jung M AU - Janicot M AU - van Emelen K PY - 2007 JO - British journal of cancer DO - 10.1038/sj.bjc.6604025 UR - https://doi.org/10.1038/sj.bjc.6604025 ER -
APA
J, A., P, A., A, M., W, F., B, J., P, K., J, V. D., L, J., T, G., RW, T., DL, J., L, A., M, J., M, J., & K, V. E. (2007). R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies.. British journal of cancer. https://doi.org/10.1038/sj.bjc.6604025
Source records
- pubmed · retrieved 2026-09-25T04:18:12.679Z